Asio Capital’s AstraZeneca AZN Stock Holding History

Asio Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.59M	Buy	+29,491	New	+$5.55M	0.72%	45
2026 Q1	–	Sell	-29,902	Closed	-$5.5M	–	112
2025 Q4	$5.5M	Buy	29,902 +467	+2%	+$81.9K	0.78%	46
2025 Q3	$4.52M	Buy	29,435 +773	+3%	+$117K	0.68%	53
2025 Q2	$4.01M	Buy	28,662 +1,577	+6%	+$221K	0.67%	55
2025 Q1	$3.98M	Buy	27,085 +314	+1%	+$45.4K	0.77%	44
2024 Q4	$3.51M	Buy	26,771 +2,785	+12%	+$390K	0.66%	52
2024 Q3	$3.74M	Buy	23,986 +861	+4%	+$139K	0.71%	49
2024 Q2	$3.61M	Buy	23,125 +458	+2%	+$68.9K	0.74%	47
2024 Q1	$3.07M	Buy	+22,667	New	+$3M	0.65%	56

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Asio Capital's AZN Position: Q2 2026 in Review

Asio Capital opened a new position in AstraZeneca (AZN) in Q2 2026: 29,491 shares worth $5.59M. The stake represents 0.72% of the portfolio and ranks #45 among its holdings. This is a return to the name: Asio Capital previously reported a position in AZN as recently as Q4 2025.

Asio Capital first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Asio Capital held 29,491 shares of AstraZeneca worth $5.59M as of Q2 2026.
AstraZeneca was a new Asio Capital position in Q2 2026.
AstraZeneca made up 0.72% of Asio Capital's portfolio in Q2 2026, its #45 holding.
Asio Capital first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Asio Capital's 13F filing for Q2 2026, filed 17 Jul 2026.